OraSure Technologies, Inc.

OSUR Healthcare Medical Instruments & Supplies

OraSure Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $115.0 million, down 38.1% from fiscal 2024. In the quarter to June 2026, revenue fell 1.93%, EPS grew 134.6%, free cash flow fell 1.40% and total debt fell 8.27%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

3.61 0.20 −5.25%
Market cap
$262.8M
P/E
0.0×
Fwd P/E
−3.9×
Dividend yield
—
F-score
3/9
Altman Z
1.47
Beneish M
−2.73
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 11.50 0.00 0.00 0.00 29.74 34.35 36.40 25.11
Piotroski F-Score
3 5 8 4 1 3 2 6 5 9
Altman Z-Score
1.47 2.97 8.60 3.60 5.34 8.35 8.00 14.46 18.75 13.99
P/S ratio
1.55 1.45 1.50 0.90 2.68 4.16 3.20 3.93 6.82 3.81
P/FCF ratio
0.00 11.40 4.63 0.00 0.00 0.00 1,010.71 21.80 47.82 24.15
Altman Z″-Score (non-manufacturers)
6.76 9.22 13.27 7.24 7.26 10.21 10.84 12.80 10.91 11.52
Beneish M-Score
(2.73) (2.76) (3.69) (1.59) (2.28) (2.65) (2.26) (2.77) (1.47) (2.48)
P/Operating CF
(19.77) 2,465.20 14.68 (19.28) (48.93) 197.97 (478.97) 49.97 (516.59) (839.96)
P/B ratio
0.52 0.65 1.41 0.95 1.64 1.79 1.61 2.52 4.41 2.63
Price to Tangible BV
0.64 0.76 1.54 1.09 1.92 2.10 1.93 2.75 4.96 3.12
EV/Sales
(0.19) 0.01 0.78 0.61 2.03 2.95 2.20 3.07 5.89 2.87
EV/EBITDA
0.35 0.00 5.91 0.00 317.55 120.28 13.11 15.98 21.23 14.18
EV/Operating CF
0.44 0.04 2.24 (5.02) (13.41) 87.20 34.71 14.25 34.92 14.96
EV/FCF
0.40 0.04 2.42 (2.13) (5.68) (24.27) 694.46 17.02 41.28 18.17
Quick Ratio
5.57 8.71 8.36 2.63 2.91 5.34 5.91 6.84 6.16 8.12
Current Ratio
6.58 9.95 9.77 4.71 4.40 6.21 6.86 7.84 6.88 9.02
Net Debt/EBITDA
3.22 15.40 (5.41) 16.11 (101.13) (49.53) (5.97) (4.49) (3.37) (4.66)
Debt/Assets
0.02% 0.02% 0.05% 0.11% 0.42% 0.20% 0.39% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.26 0.39 0.87 0.86 0.51 0.43 0.47 0.59 0.66 0.65
Operating CF/Net income
0.71 (1.40) 2.64 2.76 1.54 (0.39) 0.59 1.92 0.91 1.25
Capex/Depreciation
(0.41) (0.35) (0.49) (4.17) (4.13) (3.08) (1.27) (0.98) (0.71) (0.77)
ROE
(18.30%) (4.64%) 13.50% (4.60%) (5.90%) (4.23%) 5.64% 7.53% 13.94% 11.42%
ROA
(15.57%) (4.05%) 11.58% (3.79%) (5.02%) (3.71%) 5.01% 6.67% 12.28% 9.93%
ROIC
(31.75%) (12.37%) 14.54% (5.45%) (2.77%) (1.70%) 7.64% 14.01% 24.61% 19.52%
Return on Tangible Assets
(26.30%) (5.65%) 13.68% (5.43%) (7.55%) (5.07%) 7.50% 9.46% 14.66% 12.39%
Average Days of Receivables
70.46 46.78 36.16 66.69 70.79 82.55 87.23 69.97 92.90 56.45
Research and Development Expense of Revenue
36.97% 14.02% 8.32% 9.35% 14.62% 18.07% 12.70% 8.94% 8.00% 7.61%
Selling, General and Administrative Expense of Revenue
64.16% 41.54% 23.31% 30.31% 40.69% 44.91% 43.44% 37.93% 34.63% 45.25%
Intangible Assets out of Total Assets
0.15 0.12 0.08 0.11 0.12 0.13 0.15 0.08 0.10 0.14
Share Based Compensation of Revenue
8.82% 6.41% 2.65% 3.00% 3.34% 4.16% 2.62% 8.38% 4.17% 4.73%
Graham Net Nets
1.12 0.98 0.55 0.71 0.35 0.33 0.37 0.26 0.16 0.27
Graham Number
0.00 0.00 9.75 0.00 0.00 0.00 5.50 5.96 7.22 5.13
Earnings Yield
(38.43%) (7.20%) 8.70% (5.43%) (3.68%) (2.22%) 3.36% 2.91% 2.75% 3.98%
Free Cash Flow Yield
(29.93%) 8.77% 21.62% (31.96%) (13.35%) (2.92%) 0.10% 4.59% 2.09% 4.14%
Revenue per Share
1.57 2.50 5.53 5.34 3.25 2.54 2.51 2.97 2.83 2.31
Operating CF per Share
(0.67) 0.37 1.93 (0.65) (0.49) 0.09 0.16 0.64 0.48 0.44
Capex per Share
(0.06) (0.05) (0.14) (0.88) (0.67) (0.43) (0.15) (0.10) (0.07) (0.08)
Free Cash Flow per Share
(0.72) 0.32 1.79 (1.53) (1.16) (0.34) 0.01 0.54 0.40 0.36
Cash per Share
2.71 3.60 3.96 1.53 2.13 3.10 2.53 2.56 2.64 2.17
Shareholders Equity per Share
4.64 5.51 5.87 5.03 5.29 5.90 4.98 4.64 4.37 3.34
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
4.64 5.51 5.87 5.03 5.29 5.90 4.98 4.64 4.37 3.34
Free Cash Flow
(53.22) 23.58 131.28 (110.99) (83.50) (23.12) 0.49 32.75 23.82 20.25
Working Capital
222.11 299.74 346.92 256.13 231.24 242.40 191.84 191.33 189.67 139.11
Capital Expenditures
(4.20) (3.80) (10.30) (63.79) (48.12) (28.92) (9.31) (6.34) (4.34) (4.35)
Net Current Asset Value
199.57 263.90 334.29 245.44 218.85 232.99 182.40 187.12 183.79 134.36
EV/EBIT
0.30 0.00 9.70 0.00 0.00 0.00 18.28 19.60 24.43 18.15
Capex to Sales
0.04 0.02 0.03 0.16 0.21 0.17 0.06 0.03 0.03 0.03
Price to Operating Income
0.00 0.00 18.58 0.00 0.00 0.00 26.61 25.11 28.31 24.12
Other line items
Depreciation/Fixed assets
0.26 0.24 0.46 0.26 0.16 0.18 0.24 0.27 0.28 0.28
Cash ROIC
(9.85%) 3.48% 18.20% (23.33%) (15.59%) (3.80%) 0.11% 7.44% 5.75% 6.60%
Accounts Receivable Turnover
5.00 5.81 7.31 6.67 5.55 4.53 4.31 4.70 5.36 6.56
Accounts Payable Turnover
9.10 9.98 9.14 7.24 5.11 5.18 5.95 6.54 9.17 8.27
Inventory Turnover
2.05 2.60 3.26 3.21 2.73 2.54 2.61 3.23 4.37 3.21
Average Days of Payables
35.62 28.03 20.53 58.05 88.12 90.96 58.18 56.78 54.81 42.10
Days of Inventory on Hand
169.66 117.27 74.33 146.13 167.09 166.49 140.81 122.62 103.66 107.21
Average Receivables
23.01 31.99 55.48 58.06 42.08 37.89 35.90 38.68 31.17 19.55
Average Payables
7.35 10.66 25.59 33.02 22.72 13.49 10.08 10.41 7.43 4.86
Average Inventory
32.63 40.91 71.66 74.42 42.50 27.51 23.02 21.12 15.57 12.52
Average Assets
441.41 481.25 463.51 452.59 457.73 401.88 332.43 305.89 252.07 198.63
Average Common Equity
375.58 420.50 397.55 372.48 389.55 352.86 295.26 270.73 221.97 172.64

Fold the line items

Columns are period end dates